GLP-1 Medications: Ozempic, Wegovy, and Beyond

If you have watched the news, scrolled through social media, or spoken with friends recently, you have likely heard about the revolution happening in diabetes and weight management. The rise of GLP-1 medications has fundamentally shifted how we approach metabolic health.

At Kelsey-Seybold Clinic in Sugar Land, questions about these medications are among the most frequent I receive. Patients want to know: Are they safe? Do they really work? Am I a candidate?

While the headlines often focus on celebrity transformations, the medical reality is far more compelling. These treatments offer a new horizon for patients struggling with Type 2 diabetes and obesity, targeting the root biological drivers of these conditions rather than just treating the symptoms.

Understanding the GLP-1 Revolution

To understand why these drugs are effective, we need to look at how our bodies handle sugar and hunger. GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in the intestines after you eat. Natural GLP-1 has a very short lifespan — often just minutes. The medications we prescribe, known as GLP-1 receptor agonists, are engineered to resist breakdown and remain active for days, usually allowing for a convenient once-weekly injection.

How They Work

These medications act like a master switch for your metabolism, working through four coordinated mechanisms:

1. Insulin Production: They signal your pancreas to release insulin when blood sugar is high, helping lower glucose levels effectively. Because this response is glucose-dependent, the risk of hypoglycemia is lower than with some older diabetes drugs.

2. Glucagon Suppression: They reduce the release of glucagon, a hormone that triggers your liver to release stored sugar into your bloodstream.

3. Gastric Emptying: They slow the speed at which food leaves your stomach, keeping you fuller longer and preventing sharp post-meal blood sugar spikes.

4. Brain Signaling: They target receptors in the brain that control appetite and cravings, effectively turning down the “food noise” that many patients struggle with daily.

The combined result is improved blood sugar control and, for many, significant weight loss. This dual action on metabolism and appetite is what makes GLP-1 medications unique.

The Medication Landscape

Navigating the brand names can be confusing. Many of these drugs contain the same active ingredient but are approved for different uses and marketed under different names.

Semaglutide (Ozempic, Wegovy, Rybelsus)

Semaglutide is currently the most well-known molecule in this class.

• Ozempic: FDA-approved for Type 2 diabetes. Helps lower blood sugar and reduces the risk of major cardiovascular events in adults with Type 2 diabetes and known heart disease.
• Wegovy: Contains the same medication as Ozempic but is approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
• Rybelsus: The oral tablet form of semaglutide, approved for Type 2 diabetes. While injectable versions often provide more predictable absorption, the oral option is excellent for patients who prefer to avoid needles.

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide represents the “beyond” in the GLP-1 conversation. It is a dual agonist that mimics two hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).

• Mounjaro: Approved for Type 2 diabetes.
• Zepbound: Approved for chronic weight management.

By targeting two different hormone receptors, tirzepatide has shown even greater efficacy in clinical trials — both for blood sugar control and weight reduction — compared to GLP-1-only agonists.

Other GLP-1 Medications

• Trulicity (dulaglutide): A weekly injection for Type 2 diabetes with proven cardiovascular benefits.
• Victoza (liraglutide): A daily injection for diabetes. Saxenda is the higher-dose version approved for weight loss.

Benefits Beyond the Scale

As an Internal Medicine physician, my primary goal is your overall longevity and vitality, not just the number on the scale. What excites me most about these therapies are the systemic health benefits emerging from long-term studies.

Cardiovascular Protection

For patients with Type 2 diabetes and established cardiovascular disease, GLP-1 medications have been shown to significantly reduce the risk of heart attack, stroke, and cardiovascular death. This is a profound development for patients at high cardiac risk.

Kidney Health

Newer research highlights protective effects on the kidneys, slowing the progression of diabetic chronic kidney disease — a serious complication of long-standing diabetes.

Liver Health

Semaglutide has received FDA approval to treat metabolic dysfunction-associated steatohepatitis (MASH), a condition causing liver inflammation and scarring. This is a breakthrough for a condition that previously had limited pharmacological options.

Sleep Apnea

Obstructive sleep apnea is a common comorbidity with obesity. Tirzepatide has shown remarkable results in improving sleep apnea severity, likely due to the significant weight reduction achieved.

Who Is a Candidate?

During a consultation, we review your full medical history to determine eligibility. Generally, these medications are appropriate for:

• Type 2 Diabetes: Patients whose blood sugar is not controlled with metformin or lifestyle changes alone.
• Obesity: Individuals with a Body Mass Index of 30 or higher.
• Overweight with Comorbidities: Individuals with a BMI of 27 or higher accompanied by weight-related conditions such as hypertension, high cholesterol, or sleep apnea.

These medications are not indicated for Type 1 diabetes or for cosmetic weight loss purposes. They are tools for chronic disease management under medical supervision.

Who Should Avoid These Medications?

Contraindications include:

• A personal or family history of medullary thyroid carcinoma (MTC).
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• A history of pancreatitis.
• Pregnancy or plans to become pregnant.
• Serious gastrointestinal disease, such as clinically meaningful pre-existing gastroparesis.

Managing Side Effects

Transparency is key to a successful treatment plan. The most common side effects are gastrointestinal, which makes sense given how these drugs slow digestion.

Gastrointestinal Discomfort

Nausea, vomiting, diarrhea, or constipation are common, especially when starting the medication or increasing the dose. These symptoms usually subside as your body adjusts. To mitigate them, we start with a low dose and increase gradually over several months.

The “Gastroparesis” Concern

You may have read about “stomach paralysis.” It is important to distinguish between the therapeutic effect of the drug and a pathological condition. These drugs intentionally delay gastric emptying to keep you full and blunt blood sugar spikes. However, for patients who already have gastroparesis, these medications can worsen symptoms and are generally not recommended.

Muscle Mass Preservation

Rapid weight loss can sometimes lead to muscle loss (sarcopenia). Maintaining muscle is vital for your metabolism and long-term mobility. This is why medication must be paired with intentional lifestyle adjustments, particularly strength training and adequate protein intake.

Practical Guide to Success on GLP-1 Therapy

These medications are tools, not magic solutions. To get the best results and minimize side effects, pair the medication with intentional lifestyle changes.

Prioritize Protein

Because your appetite will decrease, you will eat less food overall. This makes the quality of your food critical. Prioritize lean protein (chicken, fish, tofu, beans) to protect your muscle mass. If you are not eating enough protein, your body may break down muscle for energy, lowering your metabolism over time.

Hydration Is Non-Negotiable

GLP-1 medications can reduce your thirst mechanism. Combined with potential nausea, dehydration is a real risk. Carry a water bottle and sip throughout the day, aiming for clear or pale-yellow urine.

Strength Training

To counteract potential muscle loss, incorporate resistance training at least two days a week. Bodyweight exercises, resistance bands, or light dumbbells are excellent starting points.

Listen to Your Body

The portion sizes you used to eat will likely make you feel uncomfortably full or nauseated. Eat slowly. Stop before you feel full. The delayed gastric emptying means your brain receives the “full” signal later than usual.

Injectable Versus Oral: Understanding Your Options

• Injectable GLP-1s (Ozempic, Wegovy, Trulicity, Mounjaro): Typically administered once weekly via a pre-filled pen injector. The injection bypasses the digestive system, leading to more consistent absorption.
• Oral GLP-1 (Rybelsus): A daily pill taken on an empty stomach with a sip of water, followed by a 30-minute wait before eating. Absorption can be more variable, and weight-loss efficacy in studies has generally been less pronounced than with injectable forms.

The choice depends on your health goals, lifestyle, insurance coverage, and comfort with needles. For significant weight loss, injectable semaglutide or tirzepatide currently have the strongest evidence.

Cost and Insurance

These medications are expensive, often costing hundreds of dollars per month without insurance. Coverage varies by plan, and many insurers require prior authorization. Most pharmaceutical companies offer patient support programs or savings cards that can reduce out-of-pocket costs. We work with patients to navigate this process.

The Future of GLP-1 Therapy

The landscape is evolving rapidly. Oral formulations like orforglipron are in development, promising the convenience of a daily pill without the complex dosing requirements of current oral options. Triple agonists targeting three hormone receptors are in clinical trials. The trajectory is clear: more effective, more convenient, and more accessible treatments are on the horizon.

Taking the Next Step

If you are struggling with Type 2 diabetes or weight management and feel like you have tried everything without long-term success, it may be time to discuss whether a GLP-1 receptor agonist is right for you.

Medicine is personal. What works for your neighbor might not be the right choice for your unique physiology. That is why a comprehensive evaluation is the first step. At Kelsey-Seybold Clinic in Sugar Land, we look at the whole picture — your hormonal health, lifestyle, cardiac risk, and personal goals. Together, we can create a plan that helps you achieve sustainable health.

—

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for personalized medical guidance. To schedule an appointment with Dr. Vuslat Muslu Erdem, call (713) 442-9100.